NeXT Personal, a liquid biopsy test offers early lung cancer detection through ctDNA analysis, improving survival predictions ...

Liquid biopsy is ... fluids for cancer cells. Experts suggest that liquid biopsies are becoming more widely recognised, especially when it comes to diagnosing and treating lung cancer.

Combining genomics data from the TRACERx non-small-cell lung cancer (NSCLC) cohort and experimental data, we report that alterations in FAT1 are selected early during lung cancer evolution and ...

A groundbreaking study from the University of St Andrews School of Medicine has shown that biomarker testing in individuals ...

Thoracoscopic procedures reduce morbidity and the length of hospitalization compared to lung biopsy through open thoracotomy, while providing comparably diagnostic specimens. Percutaneous ...

The NSCLC pipeline report provides detailed profiles of pipeline assets, a comparative analysis of clinical and non-clinical ...

Oxford Cancer Analytics Raises USD$11M in Series A Funding to Transform Early Lung Cancer Detection and Enable Curative ...

The global cancer biopsy market size was valued at USD 30.96 billion in 2024 and is estimated to reach from USD 33.38 billion ...

Lung cancer is still the number one cause of cancer death, according to the report — but many people don't get screened for it. "A government task force recommends annual low dose CT scan for ...